Search

Natural language processing (NLP) systems are a key branch of artificial intelligence that allows machines to understand, interpret and generate human language in a more sophisticated way.

We talk about innovation in the technology sector with Natalia de la Figuera and Josep Lluís Falcó, founding partners of GÉNESIS Biomed, silver sponsor of BIOSPAIN 2023.

We spoke with Mariona Sanz Ausàs, Head of Innovation and Business Development at BSC, Silver Sponsor of BIOSPAIN 2023, about the company's role in technology transfer in the biotechnology sector.

We spoke with Volker Koscielny, Chief Medical Officer of Almirall, Platinum Sponsor of BIOSPAIN 2023, to understand the importance of preserving skin health.

We spoke with Josep Maria Casanovas, Executive Director, External Innovation & Licensing at Almirall, Platinum Sponsor of BIOSPAIN 2023, to learn about the key elements of the company's Business

Gurutz Linazasoro, CEO of VIVEbiotech, Bronze Sponsor of BIOSPAIN 2023, discusses the main challenges faced by advanced therapies, the main pillars of personalized and precision medicine.

Antonio Oliviero, Chief Medical Officer of Neurofix, Bronze Sponsor of BIOSPAIN 2023, discusses the status of therapy development for neurological disorders.

Enrique Berlanas, Managing Director of Merck Life Science in Spain, shares all the details of this grant program that recognizes the most outstanding emerging biotech companies with the aim of helping

José Miguel Vela, CSO of Welab, Bronze Sponsor of BIOSPAIN 2023, discusses the current gap in the innovation of new drugs and the crucial role of collaboration.

Multiple primary endpoints include reduction in agitation and aggression and overall disease improvement. Recent predefined Interim Analysis qualified PORTICO as non-futile.

Susana de Antonio Horcajo, Head of Listing Spain at Euronext and Bronze Sponsor of BIOSPAIN 2023, analyzes financing alternatives for biotech and healthcare companies.

Dámaso Molero, CEO of 3P Biopharmaceuticals, Silver Sponsor of BIOSPAIN 2023, analyzes the snapshot we observe of the 'biotech' sector and the company's plans for the future.

New synthetic biology spin-off from the Centre for Genomic Regulation (CRG) in Barcelona developing a novel proprietary platform for cytokine-based therapies targeting autoimmune and inflammatory

VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international projects in compliance with FDA

Meet Globalfinanz, our new ally. We talked to Begoña Torregrosa, partner and head of Collectives.

In recent years, Spain has achieved significant progress that has improved its ability to attract innovative talent, although many barriers still persist. We analyze the situation with LIM Global